TPO and COVID-19: Autoantibodies which have previously been reported in autoimmune diseases or COVID-19 patients were present among the most prevalent new-onset autoantibodies, including anti-TPO (thyroid peroxidase)11, anti-AQP4 (aquaporin-4)9 and anti-IFNA1 IgG.